Baker Avenue Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-39
Closed -$1.01K – 1757
2023
Q1
$1.01K Buy
39
+11
+39% +$294 ﹤0.01% 1173
2022
Q4
$662 Buy
+28
New +$755 ﹤0.01% 1226
2019
Q3
– Sell
-6,800
Closed -$451K – 253
2019
Q2
$451K Hold
6,800
– – 0.04% 178
2019
Q1
$378K Hold
6,800
– – 0.03% 200
2018
Q4
$337K Buy
+6,800
New +$416K 0.03% 212

Other funds holding TDOC

Baker Avenue Asset Management's TDOC Position: Q2 2023 in Review

Baker Avenue Asset Management sold out of Teladoc Health (TDOC) in Q2 2023, closing a stake of 39 shares — an estimated $1.01K sold.

Baker Avenue Asset Management first reported a position in TDOC in Q4 2018 and held it in 5 quarters. The position peaked at $451K in Q2 2019. 431 funds tracked by Wall St. Rank hold TDOC as of Q2 2023.

  • Baker Avenue Asset Management reported no remaining Teladoc Health position as of Q2 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 39 Teladoc Health shares in Q2 2023, an estimated $1.01K.
  • Baker Avenue Asset Management first reported a position in Teladoc Health in Q4 2018 and held it in 5 quarters.
  • Baker Avenue Asset Management's Teladoc Health position peaked at $451K in Q2 2019.
  • 431 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2023.

Based on Baker Avenue Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.